Fetal Macrosomia Treatment in India

• Clinical assessment:
  • Obstetric and Maternal Assessment: A detailed pregnancy history assesses gestational age, previous macrosomic or LGA infants, diabetes, maternal weight and weight gain, previous delivery complications, parity and other pregnancy risk factors.
  • Fundal Height Assessment: Measuring symphysis-fundal height can help identify a uterus larger than expected for gestational age. A discrepancy may prompt further assessment, although fundal-height measurement cannot diagnose macrosomia on its own.
  • Diabetes and Metabolic Assessment: Screening and monitoring for gestational or pre-existing diabetes are important because maternal hyperglycemia is strongly associated with excessive fetal growth.
  • Fetal Growth Assessment: The obstetric team evaluates fetal growth over time rather than relying on a single estimated fetal weight measurement. Other factors such as abdominal circumference, gestational age and growth trajectory may be considered.
  • Delivery Risk Assessment: Maternal pelvic factors, previous birth history, estimated fetal size, gestational age, diabetes status and other maternal or fetal conditions are considered when assessing potential delivery risks such as shoulder dystocia and birth trauma.
• Imaging Tests:
  • Obstetric Ultrasound: Used to assess fetal biometry and estimate fetal weight, including measurements such as abdominal circumference, head measurements and femur length.
  • Serial Growth Ultrasound: May be used when ongoing monitoring of fetal growth is clinically indicated.
  • Doppler Ultrasound: May be performed when there are additional concerns about placental function or fetal well-being, although Doppler assessment does not itself diagnose macrosomia.
  • Amniotic Fluid Assessment: Ultrasound can assess amniotic fluid volume because excessive fluid may coexist with diabetes or other pregnancy conditions.
  • Detailed Fetal Ultrasound: May be used when maternal diabetes or other risk factors warrant assessment for associated fetal abnormalities.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Fetal Macrosomia patients in India. These Services include:

• Pregnancy-Appropriate Physical Activity: For women without contraindications, appropriate aerobic and strength-based activity can support healthy weight management and glucose control during pregnancy.
• Blood Glucose and Lifestyle Support: Women with diabetes may benefit from structured support with glucose monitoring, meal planning, physical activity and adherence to the prescribed treatment plan.
• Postpartum Recovery: After vaginal or cesarean delivery, gradual mobility, pelvic-floor care, pain management and progressive return to normal activity may be incorporated according to the mode of delivery and maternal recovery.
• Newborn Monitoring and Family Support: Babies born with suspected macrosomia, particularly those exposed to maternal diabetes, may require monitoring for hypoglycemia and other metabolic or birth-related complications.

• There is no medicine that directly reduces fetal size once macrosomia has developed. Medical management focuses primarily on controlling maternal conditions that contribute to excessive fetal growth, particularly diabetes. Depending on the type and severity of diabetes, treatment may include dietary modification, physical activity and glucose-lowering medication such as insulin when clinically indicated.